Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 1,827,322 $ 1,255,916 $ 4,510,531 $ 2,432,826
General and administrative 631,698 392,063 1,935,599 1,815,299
Total operating expenses 2,459,020 1,647,979 6,446,130 4,248,125
Loss from operations (2,459,020) (1,647,979) (6,446,130) (4,248,125)
Other income:        
Interest income 577 8,541 23,499 72,000
Net loss (2,458,443) (1,639,438) (6,422,631) (4,176,125)
Other comprehensive income:        
Foreign currency translation gain 9 1,510 2,726 926
Comprehensive loss $ (2,458,434) $ (1,637,928) $ (6,419,905) $ (4,175,199)
Net loss per share:        
Basic and diluted $ (0.20) $ (0.15) $ (0.52) $ (0.39)
Weighted average shares outstanding:        
Weighted Average Number of Shares Outstanding, Basic and Diluted 12,582,728 11,116,409 12,432,318 10,792,413